Skip to main content

Gadobenate dimeglumine Side Effects

Medically reviewed by Last updated on Apr 30, 2022.

For the Consumer

Applies to gadobenate dimeglumine: intravenous solution


Intravenous route (Solution)

Nephrogenic Systemic Fibrosis (NSF)Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. NSF may result in fatal or debilitating systemic fibrosis affecting the skin, muscle and internal organs.The risk for NSF appears highest among patients with chronic, severe kidney disease (GFR less than 30 mL/min/1.73 m(2)) or acute kidney injury.Screen patients for acute kidney injury and other conditions that may reduce renal function. For patients at risk for chronically reduced renal function (eg, age greater than 60 years, hypertension or diabetes), estimate the glomerular filtration rate (GFR) through laboratory testing.For patients at highest risk for NSF, do not exceed the recommended gadobenate dimeglumine dose and allow a sufficient period of time for elimination of the drug from the body prior to re-administration

Side effects requiring immediate medical attention

Along with its needed effects, gadobenate dimeglumine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking gadobenate dimeglumine:


  • Anxiety
  • back pain
  • black, tarry stools
  • bladder pain
  • bloody or cloudy urine
  • blue lips and fingernails
  • blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • chest pain or discomfort
  • chills
  • confusion
  • cough
  • coughing that sometimes produces a pink frothy sputum
  • dark urine
  • decreased urination
  • deep or fast breathing with dizziness
  • difficult or labored breathing
  • difficult, burning, or painful urination
  • difficult, fast, or noisy breathing
  • difficulty with breathing or swallowing
  • dizziness
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • excessive muscle tone
  • fainting
  • fast, slow, or irregular heartbeat
  • fever
  • frequent urge to urinate
  • general feeling of discomfort or illness
  • headache
  • hives, itching, skin rash
  • inability to move the legs or arms
  • increased sweating
  • lower back or side pain
  • muscle stiffness, tension, or tightness
  • nausea
  • nervousness
  • numbness of the feet, hands, and around the mouth
  • pain in the shoulders, arms, jaw, or neck
  • pain or redness at the injection site
  • pale skin at the injection site
  • paralysis of one side of the body
  • pounding heartbeat
  • pounding in the ears
  • problems with speech or speaking
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • reddening of the skin, especially around the ears
  • seizures
  • shakiness in the legs, arms, hands, or feet
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • sugar in the urine
  • sweating
  • swelling in the legs and ankles
  • swelling of the eyes, face, or inside of the nose
  • swollen glands
  • tightness in the chest
  • tiredness
  • trembling or shaking of the hands or feet
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • yellow eyes or skin

Incidence not known

  • Lack or loss of strength
  • loss of consciousness
  • peeling of the skin
  • skin lesions

Side effects not requiring immediate medical attention

Some side effects of gadobenate dimeglumine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, rash, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • feeling hot


  • Bad, unusual, or unpleasant (after) taste
  • belching
  • blurred or loss of vision
  • change in sense of smell
  • change in taste
  • continuing ringing or buzzing or other unexplained noise in the ears
  • decreased awareness or responsiveness
  • diarrhea
  • difficulty having a bowel movement
  • difficulty with moving
  • disturbed color perception
  • double vision
  • dry mouth
  • ear pain
  • feeling unusually cold
  • halos around lights
  • hearing loss
  • heartburn
  • indigestion
  • joint pain
  • lack or loss of strength
  • loss of bowel control
  • muscle aches, spasms, or cramps
  • night blindness
  • overbright appearance of lights
  • redness of the eye
  • severe sleepiness
  • shivering
  • stomach discomfort or upset
  • stuffy nose
  • swollen joints
  • tunnel vision
  • vomiting

For Healthcare Professionals

Applies to gadobenate dimeglumine: intravenous solution


Cardiovascular side effects have included hypertension, vasodilatation, and tachycardia.[Ref]


Gastrointestinal side effects have included nausea, vomiting, and diarrhea.[Ref]


Hematologic side effects have included anemia.[Ref]

Nervous system

Nervous system side effects have included headache, paresthesia, and dizziness.[Ref]


Dermatologic side effects have included rash.[Ref]


General side effects have included taste perversion.[Ref]


Local side effects have included pain and injection site reactions.[Ref]


Hypersensitivity side effects have included anaphylactic and anaphylactoid reactions involving cardiovascular, respiratory and/or cutaneous manifestations which ranged from mild to severe. Some patients experienced circulatory collapse and died. In most cases, initial symptoms occurred within minutes of administration and resolved with prompt emergency treatment.


1. "Product Information. Multihance (gadobenate dimeglumine)." Bracco Diagnostics Inc (2005):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.